Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Dec 15, 2023

    HBM 9033 Out-license to Pfizer

  2. Aug 29, 2023

    2023 Interim Results Online Conference

  3. Mar 29, 2023

    2022 Annual Results Online Conference